首页> 外文期刊>Peptides: An International Journal >Evidence that the chromogranin B fragment 368-417 extracted from a pheochromocytoma is phosphorylated.
【24h】

Evidence that the chromogranin B fragment 368-417 extracted from a pheochromocytoma is phosphorylated.

机译:从嗜铬细胞瘤中提取的嗜铬粒蛋白B片段368-417被磷酸化的证据。

获取原文
获取原文并翻译 | 示例
       

摘要

A rabbit antiserum was raised against a synthetic peptide corresponding to residues 403 to 417 of human chromogranin B. This peptide was chosen to match the potential C-terminal end of a putative proteolytic fragment of the protein located between dibasic doublets in positions 366-367 and in positions 418-419 of the precursor. A radioimmunoassay based on this antiserum was developed and used to detect the protein or a fragment thereof in a pheochromocytoma tumor extract. One fragment was purified to homogeneity by successive reverse-phase HPLC chromatographies. The N-terminal sequence established by automated Edman degradation, was N-Y-P-S-L-E-L-D-K-M-A-H-G-Y-G-E-E-S-E-E-E-R corresponding to the 368-389 sequence of human chromogranin B. Taking into account the specificity of the antiserum used for peptide identification and alignment with the precursor sequence, we deduced that the purified peptide was chromogranin B (368-417) and represented a new peptide generated by limited proteolysis of chromogranin B. Combining electrospray mass-spectrometry and enzymatic dephosphorylation, we demonstrated that this peptide was phosphorylated.
机译:产生针对人嗜铬粒蛋白B残基403至417的合成肽的兔抗血清。选择该肽以匹配位于366-367和位置双碱基对之间的蛋白质推定蛋白水解片段的潜在C末端。在前体的位置418-419中。开发了基于该抗血清的放射免疫测定法,并用于检测嗜铬细胞瘤肿瘤提取物中的蛋白质或其片段。通过连续的反相HPLC色谱将一个片段纯化至均质。通过自动Edman降解建立的N端序列是NYPSLELDKMAHGYGEESEEE-R,对应于人类嗜铬粒蛋白B的368-389序列。考虑到用于肽鉴定和与前体序列比对的抗血清的特异性,我们推论纯化的肽是嗜铬粒蛋白B(368-417),代表由嗜铬粒蛋白B的有限蛋白水解产生的新肽。结合电喷雾质谱和酶促脱磷酸作用,我们证明该肽被磷酸化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号